Suncodin Tablet

Χώρα: Μαλαισία

Γλώσσα: Αγγλικά

Πηγή: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Δραστική ουσία:

DIHYDROCODEINE TARTRATE

Διαθέσιμο από:

SUNWARD PHARMACEUTICAL SDN. BHD.

INN (Διεθνής Όνομα):

DIHYDROCODEINE TARTRATE

Μονάδες σε πακέτο:

100 Tablet Tablets; 1000 Tablet Tablets; 100 Tablet Tablets; 100 Tablet Tablets; 500 Tablet Tablets; 500 Tablet Tablets; 1000 Tablet Tablets; 500 Tablets

Κατασκευάζεται από:

SUNWARD PHARMACEUTICAL SDN. BHD.

Φύλλο οδηγιών χρήσης

1
_ CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
SUNCODIN TABLET
Dihydrocodeine Tartrate (30mg )
WHAT IS IN THIS LEAFLET
1. What Suncodin Tablet is used for
2. How Suncodin Tablet works
3. Before you use Suncodin Tablet

_When you must not use it _

_Before you start to use it _

_Taking other medicines _
4. How to use Suncodin Tablet

_How much to use _

_When to use it _

_How long to use it _

_If you forget to use it _

_If you use too much(overdose) _
5. While you are using it

_Things you must do _

_Things you must not do _

_Things to be careful of _
6. Side effects
7. Storage and Disposal of Suncodin Tablet
8. Product Description

_What it looks like _

_Ingredients _

_MAL number _
9. Manufacturer and Product Registration
Holder
10. Date of revision
11. Serial Number
WHAT SUNCODIN TABLET IS USED FOR
It is used relief of moderate to severe pain.
HOW SUNCODIN TABLET WORKS
Suncodin Tablet contains a substance called
Dihydrocodeine
Tartrate.
It
belongs
to
a
group of medicines called analgesic, which is
used to relief pain..
BEFORE YOU USE SUNCODIN TABLET
_- When you must not use it _

If
you
have
Respiratory
depression;
obstructive airways disease.
_-Before you start to use it _
You should check with your doctor:-

If you have asthma

If you are elderly

If you have thyroid problem

If you have kidney or liver problem

If you are drinking alcohol

Please consult your doctor before start to
use Suncodin Tablet if you are pregnant,
plan to become pregnant, breast-feeding or
intend to breast-feed. Your doctor will have
weighed the risks of you taking Suncodin
Tablet against the benefits they expect it
will have for you.
_ _
_ _
_- Taking other medicines _
Some medicines when taken with Suncodin
Tablet may interfere with each other. It is
important to tell your doctor or pharmacist
about all the medicines that you are taking,
including
those
obtained
without
doctor’s
prescription. You should talk to you doctor
or
pharmacist if
you
are
on
the
f

Αρχείο Π.Χ.Π.

Each tablet contains:
Dihydrocodeine Tartrate 30mg
PHARMACODYNAMICS:
The action of dihydrocodeine tartrate is almost purely analgesic. It
is virtually
free from sedative or hypnotic effects.
30 mg given parenterally has been shown to have an analgesic potency
equivalent to that of 10 mg of morphine; in a study of oral analgesics
for the
relief of chronic pain, the same dose was found to be equivalent to
100 mg of
pethidine. In both trials, dihydrocodeine was found to have a lower
incidence
of side effects than either morphine or pethidine. It is fully active
when
administered orally and in the recommended doses, causes little or no
respiratory depression; in addition to being a potent analgesic, the
compound
also exhibits well-defined antitussive activity.
PHARMACOKINETICS:
The pharmacokinetics of dihydrocodeine may be similar to those of
codeine.
There have been few pharmacokinetic studies of dihydrocodeine. In one
study
peak plasma concentrations of dihydrocodeine were achieved 1.6 to 1.8
hours
after an oral dose of 30 and 60mg, respectively; elimination
half-lives varied
between about 3.5 and 4.5 hours. The rate of absorption was
independent of
dose and oral bioavailability was only about 20%, possibly because of
substantial first-pass metabolism in the gut wall or liver.
INDICATIONS:
For the relief of moderate to severe pain.
SIDE EFFECTS/ADVERSE REACTIONS:
Postmarketing Experience:
_Serotonin syndrome_
(See Warnings and Precautions)
_Adrenal insufficiency_
(See Warnings and Precautions)
_Androgen deficiency_
Cases of androgen deficiency have occurred with chronic use of
opioids.
Chronic use of opioids may influence the
hypothalamic-pituitary-gonadal axis,
leading to androgen deficiency that may manifest as low libido,
impotence,
erectile dysfunction, amenorrhea, or infertility. The causal role of
opioids in the
clinical syndrome of hypogonadism is unknown because the various
medical,
physical, lifestyle, and psychological stressors that may influence
gonadal
hormone levels have not been adequately controlled